| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.944 | 0 | 0.944 | Anabolic | 0.702 0.001 DBMET01495 0.404 0.001 DBMET01496 0.255 0.002 DBMET01497 | ||
| 0.8 | 0.013 | 0.8 | Transcription factor NF kappa B inhibitor | 0.776 0.014 DBMET01495 0.709 0.019 DBMET01496 0.562 0.036 DBMET01497 | ||
| 0.702 | 0.002 | 0.737 | Aromatase inhibitor | 0.737 0.002 DBMET01495 0.694 0.002 DBMET01496 0.395 0.004 DBMET01497 | DBMET01495 | |
| 0.707 | 0.029 | 0.773 | Antiinflammatory | 0.773 0.019 DBMET01495 0.698 0.031 DBMET01496 0.689 0.033 DBMET01497 | DBMET01495 | |
| 0.683 | 0.009 | 0.737 | Cholesterol antagonist | 0.644 0.013 DBMET01495 0.684 0.009 DBMET01496 0.737 0.006 DBMET01497 | DBMET01497 | |
| 0.675 | 0.035 | 0.818 | Apoptosis agonist | 0.743 0.024 DBMET01495 0.682 0.034 DBMET01496 0.818 0.015 DBMET01497 | DBMET01497 | |
| 0.607 | 0.002 | 0.631 | Androgen agonist | 0.631 0.001 DBMET01495 0.483 0.002 DBMET01496 0.351 0.003 DBMET01497 | DBMET01495 | |
| 0.597 | 0.036 | 0.703 | Caspase 9 stimulant | 0.703 0.023 DBMET01495 0.608 0.035 DBMET01496 0.515 0.054 DBMET01497 | DBMET01495 | |
| 0.551 | 0.02 | 0.607 | Immunosuppressant | 0.544 0.022 DBMET01495 0.5 0.033 DBMET01496 0.607 0.012 DBMET01497 | DBMET01497 | |
| 0.523 | 0.003 | 0.721 | Estrogen agonist | 0.721 0.002 DBMET01495 0.656 0.003 DBMET01496 0.521 0.003 DBMET01497 | DBMET01495 | |
| 0.519 | 0.014 | 0.643 | Nitric oxide antagonist | 0.643 0.008 DBMET01495 0.576 0.011 DBMET01496 0.549 0.013 DBMET01497 | DBMET01495 | |
| 0.51 | 0.007 | 0.613 | Anesthetic general | 0.613 0.004 DBMET01495 0.479 0.009 DBMET01496 0.504 0.008 DBMET01497 | DBMET01495 | |
| 0.475 | 0.004 | 0.576 | Lipocortins synthesis antagonist | 0.576 0.002 DBMET01495 0.554 0.003 DBMET01496 0.525 0.003 DBMET01497 | DBMET01495 | |
| 0.464 | 0.006 | 0.508 | Sodium/bile acid cotransporter inhibitor | 0.508 0.004 DBMET01495 0.481 0.005 DBMET01496 0.484 0.004 DBMET01497 | DBMET01495 | |
| 0.449 | 0.008 | 0.453 | Interferon gamma antagonist | 0.453 0.008 DBMET01495 0.385 0.012 DBMET01496 0.412 0.01 DBMET01497 | DBMET01495 | |
| 0.426 | 0.004 | 0.426 | Cholesterol synthesis inhibitor | 0.328 0.009 DBMET01495 0.345 0.007 DBMET01496 0.388 0.005 DBMET01497 | ||
| 0.437 | 0.021 | 0.447 | Tumour necrosis factor alpha release inhibitor | 0.447 0.02 DBMET01495 0.29 0.057 DBMET01496 0.23 0.085 DBMET01497 | DBMET01495 | |
| 0.45 | 0.04 | 0.908 | Aldehyde oxidase inhibitor | 0.908 0.003 DBMET01495 0.73 0.006 DBMET01496 0.656 0.012 DBMET01497 | DBMET01495 | |
| 0.403 | 0.002 | 0.403 | 5-Alpha-reductase inhibitor | 0.361 0.002 DBMET01495 0.355 0.002 DBMET01496 0.32 0.003 DBMET01497 | ||
| 0.403 | 0.005 | 0.529 | Androgen antagonist | 0.529 0.004 DBMET01495 0.409 0.005 DBMET01496 0.423 0.004 DBMET01497 | DBMET01495 | |
| 0.395 | 0.005 | 0.691 | Estrogen antagonist | 0.691 0.003 DBMET01495 0.546 0.004 DBMET01496 0.378 0.005 DBMET01497 | DBMET01495 | |
| 0.413 | 0.026 | 0.423 | DNA damaging | 0.423 0.024 DBMET01495 0.223 0.098 DBMET01496 | DBMET01495 | |
| 0.392 | 0.012 | 0.392 | Platelet adhesion inhibitor | 0.251 0.049 DBMET01495 0.133 0.128 DBMET01496 | ||
| 0.403 | 0.037 | 0.442 | Apoptosis antagonist | 0.442 0.029 DBMET01495 0.301 0.085 DBMET01496 0.436 0.03 DBMET01497 | DBMET01495 | |
| 0.358 | 0.009 | 0.453 | Interleukin 6 antagonist | 0.453 0.005 DBMET01495 0.441 0.005 DBMET01496 0.133 0.118 DBMET01497 | DBMET01495 | |
| 0.386 | 0.037 | 0.474 | Antioxidant | 0.449 0.027 DBMET01495 0.363 0.043 DBMET01496 0.474 0.023 DBMET01497 | DBMET01497 | |
| 0.349 | 0.003 | 0.505 | Estradiol 17 beta-dehydrogenase inhibitor | 0.472 0.002 DBMET01495 0.505 0.002 DBMET01496 0.319 0.003 DBMET01497 | DBMET01496 | |
| 0.396 | 0.051 | 0.404 | Immunostimulant | 0.404 0.048 DBMET01495 0.353 0.064 DBMET01496 0.354 0.063 DBMET01497 | DBMET01495 | |
| 0.38 | 0.035 | 0.625 | Hypoxia-inducible factor 1 alpha inhibitor | 0.588 0.008 DBMET01495 0.55 0.01 DBMET01496 0.625 0.006 DBMET01497 | DBMET01497 | |
| 0.387 | 0.043 | 0.387 | Spasmolytic | 0.188 0.13 DBMET01495 | ||
| 0.364 | 0.02 | 0.364 | P-glycoprotein inhibitor | 0.339 0.023 DBMET01495 0.188 0.073 DBMET01496 0.171 0.089 DBMET01497 | ||
| 0.367 | 0.027 | 0.436 | DNA synthesis inhibitor | 0.436 0.018 DBMET01495 0.341 0.032 DBMET01496 0.302 0.043 DBMET01497 | DBMET01495 | |
| 0.353 | 0.014 | 0.45 | Phospholipase C inhibitor | 0.45 0.008 DBMET01495 0.247 0.025 DBMET01496 0.423 0.009 DBMET01497 | DBMET01495 | |
| 0.351 | 0.019 | 0.395 | Hepatoprotectant | 0.395 0.014 DBMET01495 0.309 0.027 DBMET01496 0.379 0.015 DBMET01497 | DBMET01495 | |
| 0.33 | 0.014 | 0.575 | NOS3 expression enhancer | 0.575 0.004 DBMET01495 0.333 0.013 DBMET01496 0.277 0.021 DBMET01497 | DBMET01495 | |
| 0.316 | 0.002 | 0.353 | 5-Alpha-reductase 2 inhibitor | 0.351 0.002 DBMET01495 0.353 0.002 DBMET01496 0.228 0.003 DBMET01497 | DBMET01496 | |
| 0.356 | 0.043 | 0.59 | Interleukin 2 agonist | 0.426 0.021 DBMET01495 0.551 0.004 DBMET01496 0.59 0.004 DBMET01497 | DBMET01497 | |
| 0.311 | 0.002 | 0.385 | 5-Alpha-reductase 1 inhibitor | 0.359 0.002 DBMET01495 0.385 0.002 DBMET01496 0.199 0.003 DBMET01497 | DBMET01496 | |
| 0.354 | 0.063 | 0.354 | Antithrombotic | 0.247 0.128 DBMET01495 0.25 0.126 DBMET01497 | ||
| 0.288 | 0.005 | 0.521 | Estrogen receptor alpha antagonist | 0.521 0.003 DBMET01495 0.397 0.004 DBMET01496 0.219 0.007 DBMET01497 | DBMET01495 | |
| 0.369 | 0.091 | 0.399 | Antibacterial | 0.31 0.128 DBMET01495 0.399 0.077 DBMET01497 | DBMET01497 | |
| 0.28 | 0.003 | 0.284 | Arachidonic acid antagonist | 0.281 0.003 DBMET01495 0.269 0.003 DBMET01496 0.284 0.003 DBMET01497 | DBMET01497 | |
| 0.276 | 0.002 | 0.451 | RNA-directed RNA polymerase stimulant | 0.451 0.001 DBMET01495 0.372 0.001 DBMET01496 0.421 0.001 DBMET01497 | DBMET01495 | |
| 0.29 | 0.018 | 0.329 | Bone formation stimulant | 0.3 0.017 DBMET01495 0.329 0.014 DBMET01496 0.195 0.037 DBMET01497 | DBMET01496 | |
| 0.275 | 0.008 | 0.318 | Farnesoid X receptor antagonist | 0.318 0.005 DBMET01495 0.229 0.015 DBMET01496 0.226 0.015 DBMET01497 | DBMET01495 | |
| 0.305 | 0.041 | 0.393 | Psychostimulant | 0.215 0.072 DBMET01495 0.393 0.024 DBMET01496 0.345 0.032 DBMET01497 | DBMET01496 | |
| 0.284 | 0.023 | 0.392 | Neurotrophic factor enhancer | 0.359 0.008 DBMET01495 0.392 0.006 DBMET01496 0.362 0.008 DBMET01497 | DBMET01496 | |
| 0.307 | 0.047 | 0.316 | Angiogenesis stimulant | 0.316 0.043 DBMET01495 0.245 0.072 DBMET01496 0.271 0.061 DBMET01497 | DBMET01495 | |
| 0.259 | 0.003 | 0.259 | Bile acid receptor antagonist | 0.21 0.004 DBMET01495 0.124 0.016 DBMET01496 0.13 0.013 DBMET01497 | ||
| 0.259 | 0.006 | 0.26 | Microtubule formation inhibitor | 0.252 0.008 DBMET01495 0.227 0.014 DBMET01496 0.26 0.006 DBMET01497 | DBMET01497 | |
| 0.273 | 0.027 | 0.472 | Diuretic | 0.438 0.011 DBMET01495 0.472 0.009 DBMET01496 0.321 0.019 DBMET01497 | DBMET01496 | |
| 0.294 | 0.05 | 0.294 | Hypolipemic | 0.16 0.127 DBMET01495 0.189 0.103 DBMET01497 | ||
| 0.245 | 0.004 | 0.516 | Estrogen receptor alpha agonist | 0.516 0.002 DBMET01495 0.379 0.003 DBMET01496 0.331 0.003 DBMET01497 | DBMET01495 | |
| 0.244 | 0.003 | 0.33 | Aldosterone antagonist | 0.33 0.003 DBMET01495 0.203 0.004 DBMET01496 0.191 0.004 DBMET01497 | DBMET01495 | |
| 0.279 | 0.049 | 0.279 | Gastrin inhibitor | 0.215 0.127 DBMET01495 0.203 0.145 DBMET01496 0.259 0.069 DBMET01497 | ||
| 0.224 | 0.003 | 0.431 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.33 0.002 DBMET01495 0.431 0.002 DBMET01496 0.263 0.003 DBMET01497 | DBMET01496 | |
| 0.226 | 0.008 | 0.48 | Estrogen receptor beta antagonist | 0.48 0.004 DBMET01495 0.367 0.004 DBMET01496 0.261 0.006 DBMET01497 | DBMET01495 | |
| 0.243 | 0.028 | 0.304 | Lipid peroxidase inhibitor | 0.304 0.018 DBMET01495 0.239 0.029 DBMET01496 0.253 0.026 DBMET01497 | DBMET01495 | |
| 0.231 | 0.021 | 0.341 | Adenylate cyclase inhibitor | 0.341 0.01 DBMET01495 0.155 0.042 DBMET01496 0.175 0.032 DBMET01497 | DBMET01495 | |
| 0.239 | 0.029 | 0.28 | Protein kinase stimulant | 0.172 0.054 DBMET01495 0.23 0.032 DBMET01496 0.28 0.02 DBMET01497 | DBMET01497 | |
| 0.27 | 0.061 | 0.378 | Free radical scavenger | 0.264 0.063 DBMET01495 0.237 0.074 DBMET01496 0.378 0.033 DBMET01497 | DBMET01497 | |
| 0.208 | 0.004 | 0.355 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.326 0.002 DBMET01495 0.355 0.002 DBMET01496 0.284 0.002 DBMET01497 | DBMET01496 | |
| 0.28 | 0.077 | 0.474 | 5 Hydroxytryptamine release stimulant | 0.474 0.032 DBMET01495 0.473 0.032 DBMET01496 0.32 0.064 DBMET01497 | DBMET01495 | |
| 0.204 | 0.005 | 0.509 | Estrogen receptor beta agonist | 0.509 0.003 DBMET01495 0.383 0.003 DBMET01496 0.32 0.004 DBMET01497 | DBMET01495 | |
| 0.199 | 0.011 | 0.276 | Pregnane X receptor agonist | 0.276 0.004 DBMET01495 0.191 0.013 DBMET01496 0.194 0.013 DBMET01497 | DBMET01495 | |
| 0.203 | 0.025 | 0.283 | Alkylator | 0.283 0.014 DBMET01495 0.143 0.05 DBMET01496 0.16 0.041 DBMET01497 | DBMET01495 | |
| 0.249 | 0.073 | 0.249 | Platelet antagonist | |||
| 0.191 | 0.018 | 0.246 | Adenylate cyclase stimulant | 0.246 0.004 DBMET01495 0.187 0.02 DBMET01496 0.219 0.007 DBMET01497 | DBMET01495 | |
| 0.316 | 0.149 | 0.397 | Cyclophilin D inhibitor | 0.397 0.092 DBMET01497 | DBMET01497 | |
| 0.245 | 0.08 | 0.245 | Hypoglycemic | 0.165 0.155 DBMET01495 | ||
| 0.169 | 0.005 | 0.263 | Glycine receptor antagonist | 0.205 0.003 DBMET01495 0.23 0.003 DBMET01496 0.263 0.002 DBMET01497 | DBMET01497 | |
| 0.166 | 0.004 | 0.193 | Na+ K+ transporting ATPase inhibitor | 0.172 0.003 DBMET01495 0.155 0.005 DBMET01496 0.193 0.002 DBMET01497 | DBMET01497 | |
| 0.191 | 0.031 | 0.227 | DNA polymerase I inhibitor | 0.208 0.026 DBMET01495 0.167 0.041 DBMET01496 0.227 0.021 DBMET01497 | DBMET01497 | |
| 0.193 | 0.034 | 0.193 | Cholinergic antagonist | 0.11 0.084 DBMET01495 0.113 0.081 DBMET01497 | ||
| 0.162 | 0.005 | 0.241 | Glycine receptor agonist | 0.241 0.003 DBMET01495 0.197 0.004 DBMET01496 0.204 0.004 DBMET01497 | DBMET01495 | |
| 0.225 | 0.069 | 0.309 | RNA-directed DNA polymerase inhibitor | 0.309 0.03 DBMET01495 0.276 0.038 DBMET01496 0.296 0.032 DBMET01497 | DBMET01495 | |
| 0.197 | 0.042 | 0.336 | Melanin inhibitor | 0.218 0.035 DBMET01495 0.286 0.024 DBMET01496 0.336 0.018 DBMET01497 | DBMET01497 | |
| 0.165 | 0.01 | 0.262 | CDC25A inhibitor | 0.198 0.007 DBMET01495 0.262 0.004 DBMET01496 0.199 0.007 DBMET01497 | DBMET01496 | |
| 0.188 | 0.034 | 0.188 | Acetylcholine antagonist | 0.108 0.083 DBMET01495 0.11 0.08 DBMET01497 | ||
| 0.164 | 0.014 | 0.164 | Toll-Like receptor 4 antagonist | 0.118 0.046 DBMET01495 0.097 0.076 DBMET01496 0.101 0.068 DBMET01497 | ||
| 0.151 | 0.003 | 0.214 | Estrone sulfatase inhibitor | 0.18 0.002 DBMET01495 0.214 0.002 DBMET01496 0.183 0.002 DBMET01497 | DBMET01496 | |
| 0.186 | 0.044 | 0.186 | Insulin secretagoues | 0.15 0.075 DBMET01497 | ||
| 0.146 | 0.004 | 0.302 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.302 0.003 DBMET01495 0.07 0.005 DBMET01496 0.066 0.005 DBMET01497 | DBMET01495 | |
| 0.193 | 0.054 | 0.272 | Antipruritic | 0.154 0.09 DBMET01495 0.186 0.06 DBMET01496 0.272 0.019 DBMET01497 | DBMET01497 | |
| 0.205 | 0.068 | 0.329 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.329 0.016 DBMET01495 0.279 0.031 DBMET01496 0.283 0.029 DBMET01497 | DBMET01495 | |
| 0.214 | 0.077 | 0.355 | Antimitotic | 0.355 0.031 DBMET01495 0.32 0.039 DBMET01497 | DBMET01495 | |
| 0.226 | 0.098 | 0.464 | Interleukin agonist | 0.315 0.041 DBMET01495 0.382 0.022 DBMET01496 0.464 0.012 DBMET01497 | DBMET01497 | |
| 0.137 | 0.014 | 0.41 | Beta tubulin antagonist | 0.41 0.004 DBMET01495 0.16 0.011 DBMET01496 0.053 0.045 DBMET01497 | DBMET01495 | |
| 0.159 | 0.041 | 0.159 | Cyclooxygenase 3 inhibitor | 0.129 0.068 DBMET01495 0.126 0.071 DBMET01497 | ||
| 0.237 | 0.124 | 0.446 | Caspase 3 stimulant | 0.376 0.051 DBMET01495 0.291 0.083 DBMET01496 0.446 0.03 DBMET01497 | DBMET01497 | |
| 0.14 | 0.027 | 0.189 | Prolactin inhibitor | 0.162 0.018 DBMET01495 0.189 0.011 DBMET01496 0.129 0.032 DBMET01497 | DBMET01496 | |
| 0.13 | 0.019 | 0.3 | Keratolytic | 0.3 0.004 DBMET01495 0.266 0.005 DBMET01496 0.216 0.007 DBMET01497 | DBMET01495 | |
| 0.137 | 0.034 | 0.249 | Antineoplastic antibiotic | 0.178 0.025 DBMET01495 0.122 0.038 DBMET01496 0.249 0.014 DBMET01497 | DBMET01497 | |
| 0.114 | 0.013 | 0.388 | Alpha tubulin antagonist | 0.388 0.004 DBMET01495 0.125 0.012 DBMET01496 0.049 0.042 DBMET01497 | DBMET01495 | |
| 0.108 | 0.008 | 0.257 | Progesterone antagonist | 0.257 0.004 DBMET01495 0.228 0.004 DBMET01496 0.16 0.005 DBMET01497 | DBMET01495 | |
| 0.102 | 0.005 | 0.122 | Lipocortins synthesis agonist | 0.114 0.004 DBMET01495 0.113 0.004 DBMET01496 0.122 0.003 DBMET01497 | DBMET01497 | |
| 0.13 | 0.034 | 0.139 | Antineoplastic alkaloid | 0.112 0.041 DBMET01495 0.088 0.056 DBMET01496 0.139 0.031 DBMET01497 | DBMET01497 | |
| 0.11 | 0.015 | 0.191 | Estrogen-related receptor beta agonist | 0.191 0.003 DBMET01495 0.143 0.005 DBMET01496 0.123 0.009 DBMET01497 | DBMET01495 | |
| 0.151 | 0.057 | 0.329 | Tubulin antagonist | 0.329 0.016 DBMET01495 0.184 0.043 DBMET01496 | DBMET01495 | |
| 0.092 | 0.004 | 0.302 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.265 0.002 DBMET01495 0.302 0.002 DBMET01496 0.203 0.003 DBMET01497 | DBMET01496 | |
| 0.244 | 0.162 | 0.244 | Antiobesity | |||
| 0.087 | 0.005 | 0.167 | Glucocorticoid antagonist | 0.167 0.004 DBMET01495 0.142 0.004 DBMET01496 0.11 0.005 DBMET01497 | DBMET01495 | |
| 0.082 | 0.004 | 0.137 | Progesterone agonist | 0.136 0.003 DBMET01495 0.137 0.003 DBMET01496 0.088 0.004 DBMET01497 | DBMET01496 | |
| 0.102 | 0.024 | 0.149 | HIV-1 integrase inhibitor | 0.128 0.013 DBMET01495 0.149 0.009 DBMET01496 | DBMET01496 | |
| 0.134 | 0.057 | 0.166 | Anesthetic local | 0.135 0.057 DBMET01495 0.166 0.042 DBMET01496 0.118 0.068 DBMET01497 | DBMET01496 | |
| 0.157 | 0.081 | 0.157 | Sigma receptor agonist | |||
| 0.149 | 0.076 | 0.163 | Acetylcholine M1 receptor antagonist | 0.163 0.063 DBMET01496 | DBMET01496 | |
| 0.083 | 0.01 | 0.154 | Mineralocorticoid receptor antagonist | 0.154 0.005 DBMET01495 0.145 0.005 DBMET01496 0.095 0.008 DBMET01497 | DBMET01495 | |
| 0.076 | 0.005 | 0.076 | Farnesoid X receptor agonist | 0.074 0.006 DBMET01495 0.041 0.023 DBMET01496 0.061 0.01 DBMET01497 | ||
| 0.077 | 0.008 | 0.096 | Pregnane X receptor antagonist | 0.087 0.005 DBMET01495 0.096 0.004 DBMET01496 0.095 0.004 DBMET01497 | DBMET01496 | |
| 0.14 | 0.074 | 0.168 | Ca2+-transporting ATPase inhibitor | 0.155 0.032 DBMET01495 0.152 0.037 DBMET01496 0.168 0.015 DBMET01497 | DBMET01497 | |
| 0.126 | 0.061 | 0.126 | Acetylcholine muscarinic antagonist | 0.114 0.074 DBMET01497 | ||
| 0.102 | 0.038 | 0.102 | Acetylcholine nicotinic antagonist | 0.075 0.06 DBMET01495 | ||
| 0.066 | 0.005 | 0.443 | Glucose-6-phosphate dehydrogenase inhibitor | 0.095 0.003 DBMET01495 0.224 0.002 DBMET01496 0.443 0.001 DBMET01497 | DBMET01497 | |
| 0.076 | 0.019 | 0.109 | Heme oxygenase stimulant | 0.096 0.008 DBMET01495 0.109 0.005 DBMET01496 0.103 0.007 DBMET01497 | DBMET01496 | |
| 0.064 | 0.011 | 0.077 | Microtubule stabilization | 0.068 0.008 DBMET01495 0.049 0.029 DBMET01496 0.077 0.005 DBMET01497 | DBMET01497 | |
| 0.113 | 0.066 | 0.113 | Photosensitizer | 0.105 0.079 DBMET01497 | ||
| 0.114 | 0.067 | 0.134 | Protein-tyrosine phosphatase 1B inhibitor | 0.131 0.055 DBMET01495 0.12 0.064 DBMET01496 0.134 0.053 DBMET01497 | DBMET01497 | |
| 0.048 | 0.003 | 0.055 | Hedgehog signaling activator | 0.047 0.004 DBMET01495 0.037 0.005 DBMET01496 0.055 0.003 DBMET01497 | DBMET01497 | |
| 0.12 | 0.081 | 0.266 | Amylase inhibitor | 0.266 0.024 DBMET01495 0.167 0.056 DBMET01496 0.179 0.052 DBMET01497 | DBMET01495 | |
| 0.087 | 0.049 | 0.087 | Opioid kappa receptor antagonist | 0.074 0.069 DBMET01495 0.077 0.063 DBMET01496 0.078 0.061 DBMET01497 | ||
| 0.1 | 0.064 | 0.1 | Bronchodilator | |||
| 0.064 | 0.028 | 0.064 | Protein 50S ribosomal subunit inhibitor | 0.046 0.045 DBMET01495 0.047 0.043 DBMET01497 | ||
| 0.069 | 0.034 | 0.069 | Nitric oxide donor | 0.066 0.038 DBMET01497 | ||
| 0.036 | 0.004 | 0.05 | Corticosteroid-like | 0.046 0.003 DBMET01495 0.045 0.004 DBMET01496 0.05 0.003 DBMET01497 | DBMET01497 | |
| 0.133 | 0.103 | 0.29 | Growth hormone agonist | 0.29 0.034 DBMET01495 | DBMET01495 | |
| 0.051 | 0.023 | 0.101 | Opioid kappa receptor agonist | 0.041 0.033 DBMET01495 0.101 0.009 DBMET01497 | DBMET01497 | |
| 0.039 | 0.012 | 0.08 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.08 0.005 DBMET01495 0.047 0.009 DBMET01496 0.072 0.005 DBMET01497 | DBMET01495 | |
| 0.129 | 0.102 | 0.151 | Protein-tyrosine phosphatase inhibitor | 0.151 0.078 DBMET01495 0.146 0.083 DBMET01496 0.129 0.103 DBMET01497 | DBMET01495 | |
| 0.201 | 0.175 | 0.231 | Vasodilator, peripheral | 0.231 0.143 DBMET01495 0.218 0.156 DBMET01497 | DBMET01495 | |
| 0.032 | 0.006 | 0.054 | Glucocorticoid agonist | 0.054 0.004 DBMET01495 0.049 0.005 DBMET01496 0.054 0.004 DBMET01497 | DBMET01497 | |
| 0.066 | 0.043 | 0.069 | CDC25B inhibitor | 0.065 0.044 DBMET01495 0.069 0.038 DBMET01496 | DBMET01496 | |
| 0.027 | 0.004 | 0.027 | Vitamin D receptor agonist | 0.023 0.005 DBMET01495 0.018 0.009 DBMET01496 0.023 0.005 DBMET01497 | ||
| 0.03 | 0.009 | 0.03 | Prostaglandin F2 alpha agonist | 0.025 0.012 DBMET01497 | ||
| 0.038 | 0.017 | 0.038 | HMG CoA reductase inhibitor | 0.037 0.018 DBMET01497 | ||
| 0.182 | 0.162 | 0.316 | Transcription factor STAT3 inhibitor | 0.316 0.046 DBMET01495 0.255 0.079 DBMET01496 0.193 0.144 DBMET01497 | DBMET01495 | |
| 0.035 | 0.017 | 0.035 | Prostaglandin agonist | |||
| 0.035 | 0.018 | 0.035 | ATP citrate lysase inhibitor | 0.029 0.028 DBMET01497 | ||
| 0.036 | 0.021 | 0.046 | Tubulin agonist | 0.046 0.01 DBMET01495 0.033 0.026 DBMET01496 0.045 0.011 DBMET01497 | DBMET01495 | |
| 0.06 | 0.046 | 0.06 | Prostaglandin F2 alpha antagonist | |||
| 0.033 | 0.019 | 0.033 | Prostaglandin D2 agonist | |||
| 0.017 | 0.004 | 0.023 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.022 0.003 DBMET01495 0.022 0.003 DBMET01496 0.023 0.002 DBMET01497 | DBMET01497 | |
| 0.02 | 0.008 | 0.039 | Telomerase stimulant | 0.039 0.002 DBMET01495 0.027 0.004 DBMET01496 0.037 0.002 DBMET01497 | DBMET01495 | |
| 0.023 | 0.013 | 0.028 | Vitamin D receptor antagonist | 0.023 0.012 DBMET01495 0.021 0.018 DBMET01496 0.028 0.008 DBMET01497 | DBMET01497 | |
| 0.012 | 0.002 | 0.097 | Transcortin receptor antagonist | 0.097 0 DBMET01495 0.043 0.001 DBMET01496 0.045 0.001 DBMET01497 | DBMET01495 | |
| 0.085 | 0.076 | 0.088 | ABCA1 expression enhancer | 0.084 0.079 DBMET01495 0.088 0.07 DBMET01497 | DBMET01497 | |
| 0.043 | 0.036 | 0.108 | Adenylate cyclase 1 inhibitor | 0.108 0.004 DBMET01495 0.064 0.015 DBMET01496 0.092 0.005 DBMET01497 | DBMET01495 | |
| 0.016 | 0.009 | 0.016 | Thromboxane A2 agonist | 0.016 0.011 DBMET01497 | ||
| 0.206 | 0.204 | 0.368 | Calcium channel activator | 0.368 0.039 DBMET01495 0.288 0.104 DBMET01496 0.301 0.09 DBMET01497 | DBMET01495 | |
| 0.089 | 0.088 | 0.154 | AMP-activated protein kinase stimulant | 0.154 0.026 DBMET01495 0.097 0.075 DBMET01497 | DBMET01495 | |
| 0.077 | 0.076 | 0.113 | Transcription factor NF kappa B stimulant | 0.113 0.029 DBMET01495 0.082 0.066 DBMET01496 0.108 0.033 DBMET01497 | DBMET01495 | |
| 0.084 | 0.088 | 0.121 | Monophenol monooxygenase inhibitor | 0.121 0.061 DBMET01495 0.119 0.062 DBMET01496 0.087 0.086 DBMET01497 | DBMET01495 | |
| 0.183 | 0.188 | 0.281 | 5 Hydroxytryptamine uptake stimulant | 0.227 0.107 DBMET01495 0.254 0.077 DBMET01496 0.281 0.056 DBMET01497 | DBMET01497 | |
| 0.071 | 0.078 | 0.105 | Ornithine decarboxylase inhibitor | 0.092 0.053 DBMET01495 0.092 0.053 DBMET01496 0.105 0.039 DBMET01497 | DBMET01497 | |
| 0.028 | 0.036 | 0.052 | Estrogen-related receptor beta antagonist | 0.052 0.005 DBMET01495 0.034 0.018 DBMET01496 | DBMET01495 | |
| 0.015 | 0.027 | 0.023 | Progesterone receptor B antagonist | 0.02 0.012 DBMET01495 0.023 0.009 DBMET01496 | DBMET01496 | |
| 0.137 | 0.152 | 0.187 | Insulin sensitizer | 0.149 0.135 DBMET01496 0.187 0.087 DBMET01497 | DBMET01497 | |
| 0.016 | 0.033 | 0.03 | Dopamine D1 agonist | 0.024 0.014 DBMET01495 0.03 0.009 DBMET01496 | DBMET01496 | |
| 0.034 | 0.054 | 0.076 | Potassium channel Kv1.3 blocker | 0.068 0.016 DBMET01495 0.056 0.024 DBMET01496 0.076 0.013 DBMET01497 | DBMET01497 | |
| 0.037 | 0.062 | 0.056 | Parathyroid hormone antagonist | 0.045 0.032 DBMET01495 0.056 0.014 DBMET01497 | DBMET01497 | |
| 0.077 | 0.102 | 0.122 | Expectorant | 0.122 0.049 DBMET01495 0.091 0.079 DBMET01497 | DBMET01495 | |
| 0.008 | 0.033 | 0.025 | Ileal bile acid transport inhibitor | 0.025 0.006 DBMET01495 0.023 0.007 DBMET01497 | DBMET01495 | |
| 0.026 | 0.058 | 0.051 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.05 0.029 DBMET01495 0.048 0.032 DBMET01496 0.051 0.028 DBMET01497 | DBMET01497 | |
| 0.026 | 0.058 | 0.045 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.045 0.015 DBMET01497 | DBMET01497 | |
| 0.004 | 0.036 | 0.017 | Progesterone receptor A antagonist | 0.01 0.005 DBMET01495 0.017 0.004 DBMET01496 0.01 0.006 DBMET01497 | DBMET01496 | |
| 0.101 | 0.135 | 0.344 | Neurotrophic factor | 0.153 0.056 DBMET01496 0.344 0.006 DBMET01497 | DBMET01497 | |
| 0.017 | 0.059 | 0.025 | Vanilloid 2 agonist | 0.025 0.019 DBMET01497 | DBMET01497 | |
| 0.04 | 0.084 | 0.056 | Botulinum neurotoxin type A inhibitor | 0.056 0.044 DBMET01495 0.054 0.049 DBMET01497 | DBMET01495 | |
| 0.023 | 0.077 | 0.048 | GABA uptake inhibitor | 0.048 0.018 DBMET01496 0.046 0.019 DBMET01497 | DBMET01496 | |
| 0.017 | 0.071 | 0.041 | Estrogen-related receptor alpha antagonist | 0.041 0.017 DBMET01495 | DBMET01495 | |
| 0.058 | 0.117 | 0.089 | Inducible nitric-oxide synthase inhibitor | 0.089 0.049 DBMET01495 0.087 0.052 DBMET01496 | DBMET01495 | |
| 0.074 | 0.142 | 0.106 | Hedgehog signaling inhibitor | 0.106 0.055 DBMET01495 | DBMET01495 | |
| 0.036 | 0.107 | 0.085 | Lipase inhibitor | 0.085 0.038 DBMET01496 | DBMET01496 | |
| 0.066 | 0.155 | 0.102 | Mucolytic | 0.099 0.078 DBMET01495 0.102 0.075 DBMET01497 | DBMET01497 | |
| 0.026 | 0.116 | 0.086 | Argininosuccinate synthase inhibitor | 0.06 0.037 DBMET01495 0.055 0.041 DBMET01496 0.086 0.023 DBMET01497 | DBMET01497 | |
| 0.056 | 0.154 | 0.161 | UDP-glucose 4-epimerase inhibitor | 0.14 0.033 DBMET01495 0.121 0.043 DBMET01496 0.161 0.025 DBMET01497 | DBMET01497 | |
| 0.045 | 0.158 | 0.077 | Glutamate (mGluR6) antagonist | 0.064 0.055 DBMET01496 0.077 0.029 DBMET01497 | DBMET01497 | |
| 0.044 | 0.164 | 0.124 | Carbonic anhydrase VI inhibitor | 0.073 0.067 DBMET01495 0.124 0.028 DBMET01496 0.085 0.051 DBMET01497 | DBMET01496 | |
| 0.105 | 0.23 | 0.123 | CC chemokine 6 receptor antagonist | 0.123 0.1 DBMET01495 | DBMET01495 | |
| 0.069 | 0.216 | 0.165 | Interleukin 8 antagonist | 0.164 0.026 DBMET01495 0.165 0.026 DBMET01496 0.109 0.079 DBMET01497 | DBMET01496 | |
| 0.061 | 0.209 | 0.121 | DOPA decarboxylase inhibitor | 0.121 0.044 DBMET01496 | DBMET01496 | |
| 0.024 | 0.174 | 0.059 | Glucose-6-phosphate isomerase inhibitor | 0.059 0.019 DBMET01497 | DBMET01497 | |
| 0.103 | 0.257 | 0.191 | Cardiotonic | 0.191 0.127 DBMET01495 0.183 0.136 DBMET01497 | DBMET01495 | |
| 0.013 | 0.167 | 0.052 | Dopamine D5 agonist | 0.052 0.016 DBMET01496 | DBMET01496 | |
| 0.172 | 0.33 | 0.253 | Calcium channel L-type activator | 0.253 0.202 DBMET01496 | DBMET01496 | |
| 0.019 | 0.181 | 0.064 | GABA receptor antagonist | 0.064 0.029 DBMET01496 0.058 0.034 DBMET01497 | DBMET01496 | |
| 0.019 | 0.187 | 0.1 | Phosphofructokinase-1 inhibitor | 0.059 0.058 DBMET01495 0.1 0.032 DBMET01497 | DBMET01497 | |
| 0.035 | 0.204 | 0.181 | M18 aspartyl aminopeptidase inhibitor | 0.181 0.039 DBMET01495 | DBMET01495 | |
| 0.017 | 0.189 | 0.097 | Alcohol oxidase inhibitor | 0.078 0.025 DBMET01495 0.051 0.044 DBMET01496 0.097 0.019 DBMET01497 | DBMET01497 | |
| 0.042 | 0.226 | 0.103 | GABA C receptor agonist | 0.097 0.07 DBMET01496 0.103 0.063 DBMET01497 | DBMET01497 | |
| 0.084 | 0.271 | 0.141 | CF transmembrane conductance regulator agonist | 0.141 0.093 DBMET01495 0.136 0.104 DBMET01497 | DBMET01495 | |
| 0.116 | 0.308 | 0.287 | Transcription factor STAT inhibitor | 0.287 0.063 DBMET01495 0.226 0.106 DBMET01496 | DBMET01495 | |
| 0.041 | 0.234 | 0.106 | Cystathionine beta-synthase inhibitor | 0.106 0.07 DBMET01496 | DBMET01496 | |
| 0.11 | 0.309 | 0.277 | Angiogenesis inhibitor | 0.216 0.152 DBMET01495 0.277 0.105 DBMET01497 | DBMET01497 | |
| 0.053 | 0.262 | 0.147 | Aldehyde dehydrogenase inhibitor | 0.147 0.049 DBMET01495 0.127 0.064 DBMET01496 0.137 0.056 DBMET01497 | DBMET01495 | |
| 0.017 | 0.228 | 0.058 | Alpha-mannosidase inhibitor | 0.058 0.029 DBMET01497 | DBMET01497 | |
| 0.017 | 0.229 | 0.052 | GABA A receptor antagonist | 0.052 0.039 DBMET01496 0.051 0.039 DBMET01497 | DBMET01496 | |
| 0.111 | 0.325 | 0.236 | Immunomodulator | 0.236 0.127 DBMET01497 | DBMET01497 | |
| 0.125 | 0.343 | 0.239 | Tyrosine 3 hydroxylase inhibitor | 0.239 0.079 DBMET01496 0.182 0.173 DBMET01497 | DBMET01496 | |
| 0.056 | 0.278 | 0.128 | Interleukin 4 antagonist | 0.128 0.074 DBMET01497 | DBMET01497 | |
| 0.039 | 0.276 | 0.107 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.107 0.048 DBMET01497 | DBMET01497 | |
| 0.039 | 0.314 | 0.237 | Alpha-N-acetylglucosaminidase inhibitor | 0.136 0.064 DBMET01495 0.114 0.084 DBMET01496 0.237 0.025 DBMET01497 | DBMET01497 | |
| 0.028 | 0.318 | 0.104 | Creatine kinase inhibitor | 0.095 0.066 DBMET01495 0.104 0.055 DBMET01496 0.104 0.055 DBMET01497 | DBMET01497 | |
| 0.013 | 0.303 | 0.07 | Carbamoyl phosphate synthetase inhibitor | 0.07 0.035 DBMET01497 | DBMET01497 | |
| 0.033 | 0.327 | 0.099 | Beta glucuronidase inhibitor | 0.099 0.071 DBMET01495 | DBMET01495 | |
| 0.038 | 0.35 | 0.085 | Lanosterol 14 alpha demethylase inhibitor | 0.085 0.082 DBMET01497 | DBMET01497 | |
| 0.007 | 0.324 | 0.028 | Purinergic P2Y15 antagonist | 0.028 0.022 DBMET01497 | DBMET01497 | |
| 0.025 | 0.344 | 0.069 | Glutamate dehydrogenase inhibitor | 0.069 0.057 DBMET01497 | DBMET01497 | |
| 0.065 | 0.388 | 0.156 | Cyclic AMP phosphodiesterase inhibitor | 0.156 0.141 DBMET01497 | DBMET01497 | |
| 0.056 | 0.392 | 0.155 | Succinate dehydrogenase inhibitor | 0.155 0.103 DBMET01496 0.151 0.11 DBMET01497 | DBMET01496 | |
| 0.031 | 0.367 | 0.102 | Triose-phosphate isomerase inhibitor | 0.102 0.045 DBMET01497 | DBMET01497 | |
| 0.009 | 0.352 | 0.05 | Acyl-CoA dehydrogenase inhibitor | 0.05 0.042 DBMET01497 | DBMET01497 | |
| 0.043 | 0.401 | 0.118 | Adenylate kinase inhibitor | 0.118 0.045 DBMET01497 | DBMET01497 | |
| 0.072 | 0.432 | 0.172 | Growth factor agonist | 0.172 0.098 DBMET01495 0.169 0.104 DBMET01496 0.17 0.102 DBMET01497 | DBMET01495 | |
| 0.046 | 0.408 | 0.104 | Glutamate release inhibitor | 0.104 0.036 DBMET01497 | DBMET01497 | |
| 0.022 | 0.401 | 0.092 | GABA C receptor antagonist | 0.092 0.091 DBMET01496 | DBMET01496 | |
| 0.005 | 0.387 | 0.041 | Guanylate cyclase inhibitor | 0.041 0.032 DBMET01497 | DBMET01497 | |
| 0.03 | 0.43 | 0.095 | NADH dehydrogenase inhibitor | 0.095 0.05 DBMET01497 | DBMET01497 | |
| 0.047 | 0.511 | 0.263 | 15-Lipoxygenase inhibitor | 0.263 0.155 DBMET01496 | DBMET01496 | |
| 0.05 | 0.65 | 0.221 | GABA C receptor rho-3 antagonist | 0.221 0.183 DBMET01496 | DBMET01496 | |
| 0.064 | 0.69 | 0.166 | Nitric-oxide synthase stimulant | 0.166 0.164 DBMET01497 | DBMET01497 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |